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Background: Alcohol, tobacco, and other drug use are among the most prevalent and important health disparities
affecting sexual and gender minority (SGM; e.g., lesbian, gay, bisexual, transgender) populations. Although
numerous government agencies and health experts have called for substance use intervention studies to address
these disparities, such studies continue to be relatively rare.
Method: We conducted a scoping review of prevention and drug treatment intervention studies for alcohol, to
bacco, and other drug use that were conducted with SGM adults. We searched three databases to identify
pertinent English-language, peer-reviewed articles published between 1985 and 2019.
Results: Our search yielded 71 articles. The majority focused on sexual minority men and studied individual or
group psychotherapies for alcohol, tobacco, or methamphetamine use.
Conclusion: Our findings highlight the need for intervention research focused on sexual minority women and
gender minority individuals and on cannabis and opioid use. There is also a need for more research that evaluates
dyadic, population-level, and medication interventions.

1. Introduction
Over the past 20 years, an increasing number of studies have re
ported sexual orientation– and gender identity–related disparities in
mental and physical health—with sexual and gender minority (SGM;
lesbian, gay, bisexual and transgender) individuals being at substan
tially greater risk than heterosexual people (American Academy of
Nursing, 2016; Caceres et al., 2019; Muller & Hughes, 2016; National
Academies of Sciences, 2020). These studies have resulted in greater
understanding of the health care needs of SGM populations and the
challenges they face in accessing care and attaining/maintaining good
health.
Disparities associated with alcohol, tobacco, and other drug use are

among the most prevalent sexual orientation– and gender identity–re
lated health disparities. For example, in a U.S. population–based study,
the National Survey on Drug Use and Health, sexual minority (SM; e.g.,
lesbian, gay, bisexual) respondents reported higher rates of past-year use
of cannabis, cocaine, methamphetamine, sedatives/hypnotics, halluci
nogens, inhalants, and opioids than heterosexual respondents (Medley
et al., 2016). SM respondents also reported higher rates of substance use
disorders (SUDs) involving alcohol, cannabis, or pain medications than
their heterosexual counterparts (Medley et al., 2016). A number of other
studies have found that sexual minority women (SMW), particularly
bisexual women, are more likely than heterosexual women to drink,
drink heavily, and experience alcohol-related problems and alcohol use
disorder (Hughes et al., 2020; Hughes, McCabe, et al., 2010; McCabe

Abbreviations: BAC, blood alcohol concentration; CBT, cognitive behavioral therapy; CM, contingency management; GM, gender minority; MBSCT, modified
behavioral self-control therapy; MET, motivational enhancement therapy; MI, motivational interviewing; RCT, randomized-controlled trial; SGM, sexual and gender
minority; SM, sexual minority; SMM, sexual minority men; SMW, sexual minority women; SUD, substance use disorder.
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et al., 2019; Paschen-Wolff et al., 2019; Roxburgh et al., 2016). While
little research has focused on gender minority (GM; e.g., transgender,
nonbinary) populations, evidence exists of higher rates of tobacco
(Buchting et al., 2017; Kidd, Dolezal, & Bockting, 2018), alcohol
(Coulter et al., 2015; Gilbert et al., 2018), and cannabis (Gonzalez et al.,
2017) use among GMs than among cisgender adults (i.e., individuals for
whom their gender identity aligns with sex assigned at birth).
In addition to greater risk of substance use problems, research has
identified that SGM individuals face several challenges in accessing
substance use treatment (Hunt et al., 2017; Muller & Hughes, 2016).
These challenges include the lack of SGM-specific treatment approaches
(Hughes, 2011; Lyons et al., 2015; Talley, 2013) and providers' negative
or ambivalent views about SGM patients (Eliason & Hughes, 2004;
Lombardi, 2007; Lyons et al., 2015; Mullens et al., 2017). SGM in
dividuals are also often concerned about potential negative experiences
in treatment, such as providers' bias and the safety of identity disclosure
(Benz et al., 2019; Dearing & Hequembourg, 2014; Eliason & Hughes,
2004; Lombardi & van Servellen, 2000; McCabe et al., 2010). Moreover,
there is evidence of lower satisfaction with standard treatment among
SGM individuals than among heterosexual individuals (Senreich, 2009).
While SGM people may benefit from tailored treatments that address
these barriers, 71% of treatment programs that advertise SGM-specific
services do not actually offer them (Cochran et al., 2007; Mericle
et al., 2018).
Given high rates of substance use among SGM people and treatment
access barriers, a growing number of government agencies and health
experts have called attention to the need for SGM intervention research
(American Academy of Nursing, 2016; National Academies of Sciences,
2020; Pan American Health Organization, 2013; Stonewall Interna
tional, 2016; Substance Abuse and Mental Health Services Administra
tion, 2020). However, sexual orientation and gender identity are rarely
reported in the substance use literature (Flentje et al., 2015) and rela
tively little research has addressed interventions aimed at preventing or
reducing substance use within this population. Understanding the cur
rent “state of the science” on substance use interventions for SGM people
is an important step in advancing research and practice related to SGM
health.
We conducted a comprehensive scoping review of the literature on
alcohol, tobacco, and other drug use interventions for SGM adults. Un
like previous reviews that were restricted to a particular substance or
subset of the SGM population (Baskerville et al., 2017; Berger &
Mooney-Somers, 2017; Doolan & Froelicher, 2006; Drabble & Eliason,
2012; Knight et al., 2019; Lee et al., 2014; Rajasingham et al., 2012;
Wray et al., 2016), we included studies of all substances and with
multiple SGM population groups.

keywords for each database through review of published SGM health
review articles and consultation with a health science librarian. This
resulted in three groups of search terms/keywords: (1) SGM related, (2)
substance related, and (3) intervention related. We combined the groups
using the Boolean operator “And” to identify articles with at least one
search term/keyword in each group (i.e., SGM related AND Substance
Related AND Intervention Related) (see the Appendix A for the search
syntax for each database).
We exported citations to the citation manager, Endnote (Clarivate
Analytics, 2018). We first removed duplicate citations and then
sequentially reviewed article titles and abstracts to determine which
articles met criteria for full-text review. Table 1 summarizes the exclu
sion categories used in selecting articles for the review. Next, we
reviewed full-text versions of the remaining articles using the same
exclusion categories as in the title/abstract review, with two additions:
we excluded (a) substance use interventions that included SGM people
but did not present SGM-specific data and (b) SGM-focused substance
use interventions that did not present outcome data (e.g., process pa
pers, protocol summaries, feasibility and acceptability studies). The
team sorted articles into five groups based on primary substance
(alcohol, tobacco, methamphetamine, other drugs/general substance)
or whether the intervention focused on sexual risk reduction as the
primary outcome. For each of the five groups of articles, a single
researcher reviewed all articles within that group. An additional
researcher reviewed all five groups of articles to ensure consistency in
the review process. For each article, we abstracted information about
level of intervention (e.g., individual, group, population), study location
(e.g., U.S. versus non-U.S.), study design (e.g., single-arm versus
randomized-controlled trial), target population (e.g., SM men, SM
women, GM individuals), and key findings. Finally, to reduce potential
bias in our search strategy, we revisited articles that we had excluded as
“review articles” (e.g., systematic reviews, meta-analyses) to identify
additional studies cited within those articles that met our inclusion
criteria.
3. Results
Our selection process (see Fig. 1) yielded 71 articles that met inclu
sion criteria (see Appendix B for individual article summaries). Table 2
Table 1
Exclusion categories used for title and abstract review.

2. Materials and methods

Exclusion category

Description (if applicable)

Not written in English
Not peer-reviewed

–
Conference proceedings, dissertations,
magazine articles, news alerts, opinion pieces
Research with non-human animals
(a) Articles focused solely on HIV prevalence,
treatment (e.g., antiretroviral medication), or
prevention (e.g., pre-exposure prophylaxis);
(b) articles focused on the management of
opportunistic infections in people living with
HIV; (c) articles focused solely on prevalence,
treatment, or prevention of STIs and/or viral
hepatitis. We did not exclude articles focused
on intravenous drug use or risk factors for HIV,
STIs, or viral hepatitis.
Studies with samples composed exclusively of
individuals under age 18.
Articles that did not focus on alcohol, tobacco,
or other drug use (e.g., chemotherapy trials).
Articles that specifically excluded SGM
individuals or did not state whether the study
population included SGM individuals.
Articles that did not present original research
(e.g., systematic reviews, meta-analyses).
Articles that did not describe intervention
studies (e.g., cross-sectional studies,
observational studies, case reports).

Not human
HIV/AIDS, sexually transmitted
infections (STIs), or viral
hepatitis

We utilized a scoping review methodology (Arksey & O'Malley,
2005) to examine the research question, “What types of interventions
have been studied for alcohol, tobacco, and other drug use prevention
and treatment among SGM individuals?” Scoping reviews, unlike sys
tematic reviews, are designed with the goal of describing trends and
identifying gaps in an emerging and broad area of research (Armstong
et al., 2011), such as substance interventions for SGM populations.
We searched for articles using three databases: PubMed, Embase, and
CINAHL. We restricted the search to articles published between January
1985 and August 2019. We chose 1985 as the earliest date included
because that was when the U.S. Food and Drug Administration (FDA)
approved the first commercial HIV test (Roberts, 1994). Historically, the
majority of SGM health research has focused on the prevention and
treatment of HIV/AIDS, often with substance use as a secondary
outcome (Coulter, Kenst, Bowen, and Scout, 2014). Although we dis
cussed omitting studies in which the primary outcome was HIV/AIDS,
we ultimately decided to include such articles, given that they poten
tially have broader utility. We first compiled a list of search terms and

Not adults
Not relevant
No SGM individuals
Review articles
Not an intervention
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Fig. 1. The PRISMA flow diagram for the scoping review that details database searches, title and abstract screening, and the number of full-text articles included in
the review.

summarizes study characteristics for each group of articles. Table 3
summarizes the outcome measures used in intervention trials for
alcohol, tobacco, and methamphetamine use. Fig. 2 summarizes the
cumulative number of included articles over the 35-year review timeperiod, overall, and by population subgroup.

alcohol consumption among SMM who engaged in heavy drinking
(Chavez & Palfai, 2019; Kahler et al., 2018; Santos et al., 2014; Santos
et al., 2016; Wray et al., 2019); two were designed to prevent or reduce
heavy drinking among young SMM (Millar et al., 2016; Smith et al.,
2017); four targeted SMM who engaged in both heavy and otherwise
harmful drinking (i.e., negative consequences) (Chen et al., 2014;
Kuerbis et al., 2014; Morgenstern et al., 2012; Velasquez et al., 2009);
and two focused on reducing alcohol consumption and preventing
intoxication among bar patrons (Charlebois et al., 2017; Croff et al.,
2012).
Eight interventions focused on individual psychotherapy (Chen
et al., 2014; Kahler et al., 2018; Kuerbis et al., 2014; Millar et al., 2016;
Morgenstern et al., 2007; Morgenstern et al., 2012; Santos et al., 2014;
Santos et al., 2016) and one on couple-level psychotherapy (Fals-Stewart
et al., 2009). One study (Smith et al., 2017) evaluated a group inter
vention for young SMM, while another study (Charlebois et al., 2017)
adopted a multi-pronged approach that included structural (i.e., phys
ical environment), environmental (e.g., in-bar media campaign), and
individual elements in a venue-based (gay bar) setting. One study
evaluated an online app-based intervention that incorporated motiva
tional interviewing (MI) (Wray et al., 2019). Three other studies

3.1. Alcohol
Fifteen studies evaluated the impact of interventions on alcohol
outcomes (Charlebois et al., 2017; Chavez & Palfai, 2019; Chen et al.,
2014; Croff et al., 2012; Fals-Stewart et al., 2009; Kahler et al., 2018;
Kuerbis et al., 2014; Millar et al., 2016; Morgenstern et al., 2007;
Morgenstern et al., 2012; Santos et al., 2014; Santos et al., 2016; Smith
et al., 2017; Velasquez et al., 2009; Wray et al., 2019). Nearly all of these
studies (n = 14) were conducted in the United States. The only non-U.S.
study was conducted in Canada (Smith et al., 2017).
Two studies focused on the treatment of DSM-IV alcohol use dis
order—one with sexual minority men (SMM) only (Morgenstern et al.,
2007) and one with both SMM and SMW (Fals-Stewart et al., 2009). The
remaining 13 studies focused on interventions to prevent or reduce highrisk drinking among SMM. Of these, five were interventions to reduce
3
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Table 2
Characteristics of studies included in the scoping review of intervention research for alcohol, tobacco, and other drug among sexual and gender minority individuals (N
= 71).

Study location
U.S.
Non-U.S.
Purpose of intervention
Prevention
Treatment
Combination
Intervention type
Individual, in-person psychotherapy without
medication
Individual, in-person psychotherapy with
medication
Medication only
In-person group therapy
Online/web-based
Macrosystems intervention
Other
Study design
Single-arm (uncontrolled)
Controlled, non-randomized
Randomized controlled
Sample composition
Only SM men included
SMW included but not analyzed
SMW analyzed
GM individuals included but not analyzed
GM individuals analyzed
Included a cisgender, heterosexual comparison
group
Analysis of sub-group differences
Age differences
Sex differences (i.e., SMM vs SMW)
Gender identity differences (i.e., GM vs non-GM or
GM women vs GM men)
Sexual orientation differences (e.g., lesbian vs
bisexual women)
Racial/ethnic differences
Studies with positive substance-use outcomes

Alcohol
(n = 15)

Tobacco
(n = 7)

Methamphetamine
(n = 28)

Other, multiple, or general
substance use
(n = 9)

Non-substance interventions with
substance-focused outcomes
(n = 12)

14
1

6
1

26
2

9
0

9
3

9
2
4

0
7
0

13
10
5

5
4
0

12
0
0

6

0

17

2

1

3

1

2

0

0

0
1
1
1
3

0
4
1
1
0

1
3
1
0
4

0
1
0
0
6

0
7
1
1
2

3
1
11

6
0
1

12
0
16

5
0
4

7
1
4

12
0
1
2
0
0

2
4
1
5
0
4

26
0
0
1
1
0

4
4
0
0
1
0

11
0
0
0
1
0

0
1
0

1
1
0

2
0
0

2
0
0

0
0
0

0

0

1

2

2

0
14

1
5

1
19

1
7

2
6

SGM = sexual and gender minority; SM = sexual minority; GM = gender minority; SMM = sexual minority men; SMW = sexual minority women.

evaluated combinations of individual, group, and online interventions
(Chavez & Palfai, 2019; Croff et al., 2012; Velasquez et al., 2009).
Eleven studies used randomized controlled trial (RCT) designs (Chen
et al., 2014; Croff et al., 2012; Fals-Stewart et al., 2009; Kahler et al.,
2018; Millar et al., 2016; Morgenstern et al., 2007; Morgenstern et al.,
2012; Santos et al., 2014; Santos et al., 2016; Velasquez et al., 2009;
Wray et al., 2019). Of the other four studies, two were pilot studies to
test feasibility and efficacy (Chavez & Palfai, 2019; Smith et al., 2017),
one was a bar-based intervention with control locations (Charlebois
et al., 2017), and one was an exploratory study of one component
(personalized normative feedback) of a larger intervention (Kuerbis
et al., 2014).
Most alcohol interventions included only cisgender SMM (n = 12). In
two of those studies both cisgender and GM men were eligible to
participate (Smith et al., 2017; Velasquez et al., 2009), but the study did
not include GM men in sufficient number to permit comparative or
separate analyses. Only one study included SMW and conducted sepa
rate analyses for SMW and SMM (Fals-Stewart et al., 2009). None of the
studies reported outcomes for bisexual or GM individuals or differences
in outcomes by race/ethnicity.
Most studies reported significant change in alcohol-related out
comes. Seven studies that used an RCT design showed positive outcomes
in reducing heavy drinking in treatment groups that received MI (Kahler
et al., 2018; Morgenstern et al., 2007; Smith et al., 2017), cognitive
behavioral therapy (CBT) (Chen et al., 2014; Morgenstern et al., 2007;
Santos et al., 2014), combined MI and CBT (Chen et al., 2014;

Morgenstern et al., 2012), and personalized normative feedback (i.e.,
correcting misperceptions about the prevalence of heavy drinking in
SGM populations) (Kuerbis et al., 2014). For example, a preliminary
RCT of a web-based brief MI intervention for reducing alcohol use
among SMM seeking rapid HIV testing found fewer drinking days, binge
drinking days, and alcohol-related problems in the intervention group
(Wray et al., 2019). Fals-Stewart et al. (2009) found that behavioral
couples therapy for SM individuals with alcohol use disorder and their
nondependent partners was more effective than individual treatment
alone in reducing heavy drinking in the year after treatment.
Three smaller pilot studies showed some promise for intervention
efficacy (Chavez & Palfai, 2019; Santos et al., 2016; Smith et al., 2017).
One pilot feasibility study of a mobile app focused on MI found a
reduction in past 30-day heavy drinking (Chavez & Palfai, 2019). A
feasibility study of naltrexone as an intervention for SM men with
nondependent binge drinking and methamphetamine use found re
ductions in both substances for some participants (Santos et al., 2016).
Project PRIDE, a small-group intervention designed to reduce negative
mental health outcomes associated with minority stress, found small
effect sizes for reduced drinking (Smith et al., 2017).
Two efficacy studies focused on naltrexone in combination with
psychotherapeutic interventions (Chen et al., 2014; Morgenstern et al.,
2012). One study found that adding naltrexone to Modified Behavioral
Self-Control Therapy (MBSCT, an amalgamation of CBT and MI) did not
improve outcomes over MBSCT therapy alone (Morgenstern et al.,
2012). A second study found that genotyping for the 5-HTTLPR
4
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study focusing on intent to quit (Wintemberg et al., 2017).
One study evaluated an in-person individual intervention (Covey
et al., 2009) and four evaluated group interventions (Dickson-Spillmann
et al., 2014; Eliason et al., 2012; Matthews et al., 2013; Walls & Wis
necki, 2011). Each of these articles discussed pharmacotherapy, but only
two used pharmacotherapy (nicotine-replacement alone or with
bupropion) in their interventions (Covey et al., 2009; Walls & Wisnecki,
2011). One study used an RCT design to deliver an online intervention to
SGM young adults via Facebook (Vogel et al., 2019). Wintemberg et al.
(2017) evaluated the impact of a state-wide smoke-free policy inter
vention on SGM smoking.
Two studies described interventions focused exclusively on SMM
(Covey et al., 2009; Dickson-Spillmann et al., 2014); four interventions
combined all SGM individuals (Matthews et al., 2013; Vogel et al., 2019;
Walls & Wisnecki, 2011; Wintemberg et al., 2017). Only Eliason et al.
(2012) reported outcomes separately for SMW. It is notable that five
studies included GM individuals (Eliason et al., 2012; Matthews et al.,
2013; Vogel et al., 2019; Walls & Wisnecki, 2011; Wintemberg et al.,
2017); however, none reported GM-specific outcomes. Eliason et al.'
(2012) study was the only one to examine racial/ethnic and age dif
ferences in the intervention outcomes.
Five studies showed promising results for tobacco use outcomes
(Dickson-Spillmann et al., 2014; Eliason et al., 2012; Matthews et al.,
2013; Walls & Wisnecki, 2011; Wintemberg et al., 2017); four of these
used adaptations of the American Lung Association's Freedom From
Smoking program. Freedom From Smoking combines online, phone, and
in-person group support with information about evidence-based phar
macotherapy for tobacco use disorder (American Lung Association,
2020). Dickson-Spillmann et al. (2014) conducted a pilot study in Zur
ich, Switzerland, using a 7-week group intervention based on Freedom
From Smoking, delivered in an SGM health center. Eliason et al. (2012)
and Walls and Wisnecki (2011) used The Last Drag Intervention, also
based on Freedom From Smoking, with additional content about to
bacco use in the SGM community. Matthews et al. (2013) expanded on
The Last Drag by adding SGM-inclusive language (e.g., partner instead
of husband/wife); SGM-identified facilitators (SGM-identity salience);
panel discussions with SGM health experts; and information about the
history of targeted tobacco marketing to SGM communities. Of the four
interventions based on Freedom From Smoking, all reported statistically
significant tobacco abstinence rates postintervention. Three had out
comes comparable to general population smoking cessation intervention
trials (Dickson-Spillmann et al., 2014; Eliason et al., 2012; Matthews
et al., 2013). Only Walls and Wisnecki (2011) showed a quit rate
(88.9%) that exceeded what would be expected in a general population
trial.
Wintemberg et al. (2017) examined the association of local smokefree ordinances on smoking status among SGM people recruited at
SGM-oriented events in Missouri. SGM current smokers (25%) were
significantly more likely than SGM former smokers (19%) to live in a
community without a smoke-free ordinance. SGM current smokers who
lived in communities that had instituted smoke-free policies for two or
more years reported significantly greater intention to quit (94%) than
those living in communities without a smoke-free policy (76%).

Table 3
Outcome measures used in intervention studies focused on alcohol, tobacco, and
methamphetamine use among sexual and gender minority populations.
Alcohol
• 30-day Timeline Follow back: binge drinking frequency
• 90-day Timeline Follow back: average daily or weekly consumption, drinks per day,
heavy drinking days
• Alcohol Use Disorders Identification Test (AUDIT or AUDIT-C): Hazardous drinking
• Short Inventory of Problems (SIP): drinking-related consequences
• Blood alcohol concentration
• Readiness to Change Questionnaire
• Goal Systems Assessment Battery: self-regulation for limiting alcohol use
• Composite International Diagnostic Interview (CIDI): DSM-IV-TR alcohol
dependence
• Alcohol Dependence Scale: DSM-IV alcohol dependence severity
• Miscellaneous: Heavy drinking (yes/no; 6+ drinks), sex under the influence of
alcohol
Tobacco
• Cigarettes per day (typically used to assess whether participants achieved
abstinence)
• Fagerstrom Test for Nicotine Dependence
• Intention to quit smoking
• Attitudes about smoking cessation programs
Methamphetamine
•
•
•
•
•
•
•
•
•
•

Timeline Follow back: frequency of use (past 2-week, 30-day, 2-month, or 3-month)
Any injection of methamphetamine during the study period
Amount of money spent on methamphetamine in the past 30 days
University of Minnesota Cocaine Craving Scale and Obsessive-Compulsive Drinking
Scale adapted for methamphetamine use
Behavioral Questionnaire - Amphetamine (BQA): sex under the influence
Drug Use Disorders Identification Test (DUDIT): drug-related problems
Addiction Severity Index: drug-related problems
Urine drug screen for methamphetamine metabolites
Mini-International Neuropsychiatric Interview (MINI) or Structured Clinical
Interview for DSM Disorders (SCID-IV): stimulant use disorder
Methamphetamine craving

polymorphism in the serotonin transporter gene, which has been shown
to moderate alcohol dependence risk and treatment response, might be
helpful in identifying which SGM adults with drinking problems may
benefit more from naltrexone and CBT, as opposed to less intensive
treatment (Chen et al., 2014).
One multi-level intervention in gay bars was effective in reducing
exit blood alcohol concentration (BAC; measured by breathalyzer) and
increasing intentions to reduce alcohol consumption (Charlebois et al.,
2017). The intervention had three components: freely available water,
an in-bar media campaign on drinking water to pace alcohol intake, and
normative feedback about BAC. BAC was lower among patrons exiting
the intervention sites than those at comparison sites. A second venuebased intervention appeared to be less effective. Croff et al. (2012)
found that BAC did not differ between gay bar patrons who received a
brief intervention (feedback on potential drinking risks tailored to level
of intended alcohol use) and the attention control group. However, the
authors pointed out that patrons in the intervention group who were
classified as high-risk for alcohol-related problems (i.e., based on an
estimated BAC ≥ 0.08%; calculated based on length of drinking occa
sion, planned alcohol consumption, and weight) drank significantly less
than they planned (based on actual exit BAC).

3.3. Methamphetamine
Out of 28 methamphetamine use interventions, 13 focused on
reducing use among current users or among those at risk for use (Carrico
et al., 2018; Carrico, Gómez, et al., 2015; Landovitz et al., 2015; Mim
iaga et al., 2012; Reback et al., 2012; Reback et al., 2015; Reback et al.,
2019; Reback & Shoptaw, 2014; Shoptaw et al., 2008; Shoptaw et al.,
2017; Wu et al., 2011; Zhang et al., 2018; Zule et al., 2012); 10 in
terventions focused on individuals who met criteria for methamphet
amine use disorder (Coffin et al., 2018; Colfax et al., 2011; Das et al.,
2010; Landovitz et al., 2012; Lea et al., 2017; McElhiney et al., 2009;
Mimiaga, Pantalone, et al., 2019; Reback et al., 2010; Reback et al.,

3.2. Tobacco
Seven studies described tobacco use interventions and outcomes
(Covey et al., 2009; Dickson-Spillmann et al., 2014; Eliason et al., 2012;
Matthews et al., 2013 ; Vogel et al., 2019 ; Walls & Wisnecki, 2011 ;
Wintemberg et al., 2017). All studies were conducted in the United
States, except one study conducted in Switzerland (Dickson-Spillmann
et al., 2014). All focused on treatment (as opposed to prevention), with
six studies using smoking cessation as the primary outcome and one
5

J.D. Kidd et al.

Journal of Substance Abuse Treatment 133 (2022) 108539

Fig. 2. Cumulative number of substance use intervention studies by publication date for sexual and gender minority (SGM) populations overall (A) and for sexual
minority women (SMW) (B, dashed line) and gender minority (GM) individuals (B, solid line).

2018; Shoptaw et al., 2005). The other five studies evaluated in
terventions for individuals who used methamphetamine, regardless of
whether they met criteria for methamphetamine use disorder (Burgess
et al., 2018; Carrico et al., 2014; Carrico, Nation, et al., 2015; Lyons
et al., 2014; Menza et al., 2010). More than one-half of the studies (n =
16) were RCTs. All but two studies (Burgess et al., 2018; Lea et al., 2017)
were conducted in the United States. The two non-U.S. studies were both
conducted in Australia.
Nearly all the methamphetamine intervention studies focused on
SMM (n = 26), and most samples were made up largely of non-Hispanic
white cisgender SMM. Two studies included GM participants (Carrico
et al., 2014; Zhang et al., 2018); however, only one reported findings for
this group (Zhang et al., 2018). No studies included SMW. Only two
studies examined subgroup differences in samples of SMM. Shoptaw
et al. (2017) found no sexual identity, age, or racial/ethnic differences in
intervention outcomes among 119 HIV negative SMM. Among Black SM
male couples, Wu et al. (2011) found that older age was associated with
greater postintervention methamphetamine use.
Most studies (n = 17) evaluated individual, in-person psychothera
peutic interventions. Contingency management (CM), alone or in com
bination with other modalities, was most common (Carrico et al., 2018;
Carrico, Gómez, et al., 2015; Landovitz et al., 2012; Landovitz et al.,
2015; Menza et al., 2010; Reback et al., 2010; Shoptaw et al., 2017;
Zhang et al., 2018). Overall, CM interventions were effective at reducing
methamphetamine use among SMM and transgender women. For

example, Landovitz et al. (2012) conducted a single-group pilot study
that led to significant reductions in frequency and quantity of meth
amphetamine use based on self-report and urine drug screen. A followup RCT found the CM group had more stimulant metabolite-free urine
samples than the yoked control condition group (8.9 vs. 6.1, p = 0.04)
(Landovitz et al., 2015). Similarly, Reback et al. (2010) found that,
among 131 homeless SMM, those who participated in a 24-week CM
program had greater reductions in methamphetamine use than SMM in
the control condition. Reductions were sustained at 9- and 12-month
follow-up.
Across a series of RCTs with SMM, Reback and Shoptaw (2014) found
CM in combination with SM-specific CBT led to greater reductions in
past 30-day methamphetamine use than CM alone. In another RCT,
SMM who received CM or CM + CBT had longer periods of
methamphetamine-negative urine samples than those who received CBT
alone (Shoptaw et al., 2005). Those who received culturally tailored CBT
showed no difference in methamphetamine use, compared to those who
received standard CBT. In a subsequent study, Shoptaw et al. (2017)
found stimulant-using SMM randomized to CM versus non-contingent
yoked control had greater treatment response. Last, Zhang et al.
(2018) found no significant between-group differences in stimulantusing homeless cisgender SMM or transgender women randomized to
either a nurse case-managed program combined with CM or a CM pro
gram combined with viral hepatitis education.
The remaining individual psychotherapy interventions tested a
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variety of modalities (i.e., SM-specific CBT, MI, resilient affective pro
cessing, behavioral activation, or a combination of these modalities)
(Carrico et al., 2014; Zule et al., 2012). In a sample of 128 SMM, par
ticipants randomized to SM-specific CBT had a higher percentage of
methamphetamine-negative urine samples, compared to those in the
SM-specific social support condition (Shoptaw et al., 2008). In addition,
Carrico et al. (2015) found that SMM randomized to a 4-week multi
component resilient affective processing group reported greater re
ductions in frequency of methamphetamine use postintervention than
control participants. The two studies that used behavioral activation
showed reductions in methamphetamine use among SMM. Mimiaga
et al. (2012) found that 10-session behavioral activation and HIV-risk
reduction counseling led to significant reductions in past 30-day and
3-month methamphetamine use. In a subsequent study, Mimiaga et al.
(2019) found that SMM randomized to behavioral activation plus sexual
risk reduction reported more continuous days abstinent from metham
phetamine at 6-month follow-up, compared to control participants.
Carrico and colleagues conducted two RCTs of SMM with HIV, ran
domized to either CM plus a positive affect intervention or CM alone.
They found that SMM randomized to the enhanced CM condition had
fewer methamphetamine-positive urine samples (Carrico, Gómez, et al.,
2015), and less self-reported stimulant use (Carrico et al., 2018) and less
methamphetamine craving (Carrico et al., 2018).
Three pilot studies combined individual psychotherapy/counseling
with medication. While Das et al. (2010) found reductions in
methamphetamine-positive urine with bupropion and McElhiney et al.
(2009) found reductions in self-reported methamphetamine use and
craving with modafinil, no statistically significant differences occurred
between treatment arms in these studies. Colfax et al. (2011) found that
SMM who received mirtazapine had a larger reduction in
methamphetamine-positive urine samples (29%) than the placebo group
(4%).
Three studies evaluated in-person, group, or dyadic interventions.
Lyons et al. (2014) found that a 10-week group intervention was asso
ciated with reductions in stimulant use among SMM. In contrast, Burgess
et al. (2018) found that a six-week culturally tailored group intervention
followed by peer support was associated with only modest declines in
use among SMM who used methamphetamine. In a 7-week dyadic
intervention with Black SM male couples, Wu et al. (2011) found sig
nificant reductions in methamphetamine use.
The remaining studies employed several intervention modalities,
including technology-assisted therapies, with mixed results. Reback
et al. (2018) conducted a pilot study of 34 SMM enrolled in an outpatient
methamphetamine treatment program. The study randomized partici
pants into either a self-directed condition that included access to a webbased ecological momentary assessment response dashboard, or a
counselor-supported condition that included weekly one-on-one review
of the self-monitoring data. The investigators found no differences in
methamphetamine use between treatment conditions. Reback et al.
(2015) also conducted a pilot study to test the efficacy of theory-based
text messages in reducing methamphetamine use among SMM (n =
52). They found lower frequency of methamphetamine use two months
postintervention. A subsequent study randomized 286 SMM who used
methamphetamine to one of three conditions: 1) interactive text mes
sages with peer support plus five-times-a-day automated theory-based
messages and a weekly self-monitoring text-message assessments, 2)
daily automated messages and weekly self-monitoring assessments, or 3)
weekly self-monitoring assessments only (Reback et al., 2019). No dif
ferences occurred across groups in methamphetamine use.

et al., 2009; Paul et al., 1996; Proeschold-Bell et al., 2016; Starks et al.,
2019; Wong et al., 2008; Zajac et al., 2020).1 Five studies focused on
preventing SUDs or substance use–related problems (Empson et al.,
2017; Morgenstern et al., 2009; Proeschold-Bell et al., 2016; Starks
et al., 2019; Wong et al., 2008); the remaining studies focused on
treating individuals with SUDs or supporting individuals in recovery
from SUDs (Ashford et al., 2018; Mericle et al., 2019; Paul et al., 1996;
Zajac et al., 2020).
Two studies involved interventions consisting of individual in-person
sessions: Wong et al. (2008) tested a 15-session case management
intervention, and Zajac et al. (2020) tested a CM-based intervention.
Another study evaluated an in-person group intervention (Empson et al.,
2017). Most studies evaluated multi-modality interventions such as
combined individual and group sessions (Paul et al., 1996; ProescholdBell et al., 2016), or other components and services (e.g., HIV-risk
reduction strategies, case management, recovery support services)
(Ashford et al., 2018; Mericle et al., 2019; Starks et al., 2019). Five
studies used single-arm study designs (Ashford et al., 2018; Empson
et al., 2017; Mericle et al., 2019; Paul et al., 1996; Proeschold-Bell et al.,
2016) and four were RCTs (Morgenstern et al., 2009; Starks et al., 2019;
Wong et al., 2008; Zajac et al., 2020).
Four studies recruited participants irrespective of SM status (Ashford
et al., 2018; Proeschold-Bell et al., 2016; Wong et al., 2008; Zajac et al.,
2020). However, only one study (Ashford et al., 2018) examined dif
ferences among SGM-subgroups and in comparison to heterosexual in
dividuals. In this evaluation of a peer specialist opioid harm-reduction
program, gay/lesbian participants had the lowest odds of being
administered naloxone for an opioid overdose during study participa
tion, compared to heterosexual clients. Bisexual participants had the
highest odds of receiving naloxone for an opioid overdose. Four studies
focused exclusively on SMM (Mericle et al., 2019; Morgenstern et al.,
2009; Paul et al., 1996; Starks et al., 2019) and four studies included
SMW (Ashford et al., 2018; Proeschold-Bell et al., 2016; Wong et al.,
2008; Zajac et al., 2020), but none reported outcomes separately for
SMW. One study focused on HIV-positive transgender women (Empson
et al., 2017).
Seven studies found improvements in substance use outcomes for
SGM adults (Empson et al., 2017; Morgenstern et al., 2009; Paul et al.,
1996; Proeschold-Bell et al., 2016; Starks et al., 2019; Wong et al., 2008;
Zajac et al., 2020). Among the uncontrolled studies, Empson et al.
(2017) found reductions in alcohol and drug problems among seven
transgender women living with HIV after a 12-session PTSD Seeking
Safety intervention. Paul et al. (1996) found that alcohol and drug use
reduced over a 12-month period among 455 SMM attending an SMspecific substance use treatment program. Proeschold-Bell et al.
(2016) found reductions in alcohol and drug use severity over 12 months
using an integrated health and substance use treatment intervention,
irrespective of SM status. Using more rigorous RCT designs, researchers
found evidence for effectiveness of interventions involving MI (Mor
genstern et al., 2009), substance use assessment and reflection (Starks
et al., 2019), and counseling/case management (Wong et al., 2008), and
CM (Zajac et al., 2020).
3.5. Non–substance interventions with substance-focused outcomes
Twelve studies evaluated interventions that were primarily or dually
aimed at reducing risk for HIV/STI infection/transmission but also
assessed substance-related outcomes (Buttram & Kurtz, 2017; Darrow &
Biersteker, 2008; Feinstein et al., 2018; Kurtz et al., 2013; LelutiuWeinberger et al., 2015; Liu et al., 2018; Mansergh et al., 2010; Mim
iaga, Hughto, & Reisner, 2019; Reisner et al., 2016; Sabin et al., 2019;
Williams et al., 2006; Williams et al., 2014). Consistent with the sexual

3.4. Other, multiple, or general substance use
Nine studies, all conducted in the United States, examined in
terventions targeting use of substances other than those previously
described—or interventions targeting use of multiple substances (Ash
ford et al., 2018; Empson et al., 2017; Mericle et al., 2019; Morgenstern

1
Zajac et al. (2020) was included in this scoping review because it was epublished online in 2019.
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risk reduction aim of the interventions, all of these studies reported
intervention efficacy for preventing, rather than treating, substance use
problems. Additionally, the studies focused exclusively on cisgender
SMM except for Reisner et al. (2016), who evaluated an intervention for
transgender men who have sex with men (MSM). Only three studies
were conducted outside of the United States (in China, Vietnam, and
South Africa) (Liu et al., 2018; Sabin et al., 2019; Williams et al., 2014).
Most of these studies (n = 7) evaluated in-person, group-based in
terventions (Buttram & Kurtz, 2017; Feinstein et al., 2018; Kurtz et al.,
2013; Mansergh et al., 2010; Mimiaga, Hughto, & Reisner, 2019; Reisner
et al., 2016; Williams et al., 2006). These interventions consisted of 4–6
small groups. Session content primarily focused on safe-sex education,
negotiation skills, the relationship between alcohol/other drug use and
sexual risk, and developing ways of socializing outside the context of sex
and drugs. Reisner et al. (2016), however, evaluated the LifeSkills
intervention for young transgender MSM and incorporated identityaffirmation topics with particular relevance for this population. Most
studies focused on sexual encounters broadly, while Mimiaga et al.
(2019) focused on reducing sexual risk–taking in the context of private
sex parties. Unlike the other group-based interventions that focused on
individuals at-risk for HIV/STI infection, Feinstein et al. (2018) evalu
ated a couples-based intervention, in which male couples attended
weekly sessions. In these sessions, couples developed shared definitions
of healthy and unhealthy relationship characteristics, practiced effective
communication, and engaged in an approach based on CBT and accep
tance and commitment therapy to cope with relationship stressors.
One study evaluated an online intervention (Lelutiu-Weinberger
et al., 2015). This 8-session intervention drew on MI and CBT principles.
The study conducted sessions in a live-chat format, and the study
assigned participants homework to help them practice skills outside the
sessions. Three studies evaluated national prevention outreach (Sabin
et al., 2019) or social marketing campaigns (Darrow & Biersteker, 2008;
Williams et al., 2014).
Seven studies used a single-arm design (Buttram & Kurtz, 2017;
Darrow & Biersteker, 2008; Feinstein et al., 2018; Lelutiu-Weinberger
et al., 2015; Reisner et al., 2016; Sabin et al., 2019; Williams et al.,
2014). Two of these reported improved substance use outcomes. Wil
liams et al. (2014) evaluated a peer-counseling HIV prevention inter
vention for SMM engaged in sex work in South Africa. Participants
reported greater willingness to reduce drug use, and 29% accepted
referral to drug treatment. The majority of SMM who injected drugs
agreed to adopt noninjection methods of drug use. Feinstein et al. (2018)
evaluated a HIV prevention intervention for same-sex male couples that
consisted of four weekly group sessions, led by an openly SGM facili
tator, that focused on improving communication and connectedness
between partners. Participants reported pre-post intervention re
ductions in alcohol consumption; however, this finding was significant
only for participants with high baseline internalized stigma.
Four studies were RCTs, focusing exclusively on SMM and combined
all drug use into single outcome measures (e.g., past 3-month drug use,
drug dependence symptoms) (Kurtz et al., 2013; Liu et al., 2018; Mim
iaga, Hughto, & Reisner, 2019; Williams et al., 2006). Of these, two
interventions demonstrated efficacy for improving substance use out
comes. Williams et al. (2006) found significantly greater reductions in
past 3-month drug use and injection drug use among intervention par
ticipants than control participants. Liu et al. (2018) compared outcomes
among Chinese SMM assigned to either CBT-based peer counseling
(intervention) or standard physician-delivered safer-sex counseling
(control). The intervention consisted of group and individual sessions
focused on HIV risk-factor modification, including reducing alcohol and
drug use before and during sex. Those engaged in peer counseling were
more likely to reduce drug use.

among SGM people is in its infancy. Compared to substance use inter
vention research with individuals in the general population, relatively
little literature exists about interventions to address SGM health dis
parities, and limitations of extant research prevent conclusions about
the relative impact of SGM-specific interventions. Few studies included
SMW or GM individuals. Most were U.S.-based studies and few exam
ined SGM subgroup differences. Most studies focused on individual-level
psychotherapies for alcohol, tobacco, and methamphetamine use in
uncontrolled trials without comparing culturally tailored, SGM-specific
treatments to nontailored interventions. Interventions based on CM,
CBT, and MI showed promise.
4.1. Gaps in SGM intervention research
There remains a paucity of rigorous studies on interventions that are
designed for SMW or that include adequate samples of SMW to permit
stratified analyses or comparisons with heterosexual women or SMM. Of
the studies reviewed, only two (Eliason et al., 2012; Fals-Stewart et al.,
2009) analyzed outcomes among SMW. Research on interventions for
SMW are needed, particularly those that address concurrent risk factors.
For example, among SMW, hazardous drinking often occurs in the
context of depression and anxiety (Drabble et al., 2018; Mereish et al.,
2015). Further, hazardous drinking, depression, and anxiety are strongly
associated with trauma exposure among SMW (Hughes et al., 2014;
Hughes, McCabe, et al., 2010; Hughes, Szalacha, et al., 2010; Szalacha
et al., 2017).
Only three studies had sample sizes of GM individuals that were large
enough to support separate analyses (Empson et al., 2017; Reisner et al.,
2016; Zhang et al., 2018), with one study focused on transgender MSM
(Reisner et al., 2016) and another on transgender women living with
HIV (Empson et al., 2017). Five of seven tobacco intervention studies
included GM adults, but none reported outcomes by gender identity. At
minimum, intervention studies designed to assess effectiveness of in
terventions for SGM adults should endeavor to include large enough
samples of GM individuals to assess potential differences in effectiveness
by gender identity.
Studies that examined racial/ethnic differences in outcomes were
also lacking. Only one tobacco study examined racial/ethnic differences
in outcomes (Eliason et al., 2012), no alcohol interventions examined
differences by race/ethnicity, and interventions for methamphetamine
use included samples that were predominately non-Hispanic white,
cisgender, gay or bisexual men, or MSM. The lack of attention to racial/
ethnic differences is important given that SGM people of color are
subject to stigma, prejudice, and discrimination across intersecting mi
nority identities that can increase risk for substance use (Schuler et al.,
2020). Although debate exists in the field as to whether the effects of
multiple forms of discrimination are additive, multiplicative, or even
offset one another (Velez et al., 2019), individuals with multiple
marginalized identities have unique experiences that may influence
their substance use risk and response to interventions.
4.2. Gaps in research beyond alcohol, tobacco, and methamphetamine
use
The literature on substance use interventions for SGM populations
focuses primarily on alcohol, tobacco, and methamphetamine use with
less attention to other drugs. Previous analyses of population-based data
indicate a higher prevalence of cannabis use and cannabis use disorder
among SGM adults than their non-SGM peers (Gonzalez et al., 2017;
Medley et al., 2016; Philbin et al., 2019; Trocki et al., 2009). Despite
this, we found no reports of interventions focused on reducing cannabis
use. We also found no interventions focused on cocaine, benzodiaze
pines, prescription stimulants, inhalants, or non–prescription opioid use.
The absence of interventions focused on preventing and treating opioid
misuse is particularly concerning given the major toll of the opioid
epidemic and growing evidence that SM adults have a higher prevalence

4. Discussion
This review demonstrates that substance use intervention research
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of prescription and non–prescription opioid use and use disorders than
their heterosexual peers (Medley et al., 2016). Several analyses of
population-based data indicate that opioid use and misuse may be
especially high among bisexual adults relative to heterosexual and gay/
lesbian adults in the United States (Schuler et al., 2019; Schuler &
Collins, 2020). Fewer studies have assessed opioid use among GM in
dividuals (Nuttbrock et al., 2014; Restar et al., 2020). Our findings
highlight the need for formative research to develop and test culturally
tailored interventions for cannabis, opioid, and other nonmethamphet
amine drugs among SGM adults.

alcohol, tobacco, and opioid use disorders, the reviewed studies rarely
incorporated pharmacotherapy. Those that did were predominantly
small pilot trials that were underpowered to assess efficacy. Underutilization of pharmacotherapy in tobacco intervention studies is con
cerning because clear evidence exists that medications significantly in
crease quit rates compared to behavioral treatments alone (Agency for
Healthcare Research and Quality, 2008). Similarly, evidence supports
the use of medications as first-line treatment of opioid use disorder to
reduce relapse and opioid overdose risk (Sofuoglu et al., 2019).
4.4. Limitations

4.3. Promising interventions and gaps in research beyond individual
psychotherapies

This review provides a comprehensive summary of intervention
research for alcohol, tobacco, and other drug use among SGM people.
However, our review is limited to peer-reviewed articles indexed in
three databases (PubMed, Embase, and CINAHL) and is subject to pub
lication bias. Inclusion of additional databases (e.g., PsychInfo) could
have altered these findings. Our findings are also restricted to SGM
adults. However, Coulter et al. (2019) found only two substance use
intervention studies in their systematic review of mental health, drug,
and violence interventions among SGM youth (<18 years). Finally, we
restricted our analysis to interventions that reported effectiveness or
efficacy outcomes. Therefore, we did not include feasibility or accept
ability trials. Outcomes such as treatment engagement and retention are
relevant because of the health care access barriers that many SGM in
dividuals experience (Kenagy, 2005; Lombardi & van Servellen, 2000;
Lyons et al., 2015). These access barriers may also impact recruitment
for treatment studies of SGM individuals and the generalizability of
findings. For this reason, special attention is needed to recruit sub
populations of SGM individuals who might have difficulty accessing
treatment and treatment-focused research (e.g., GM individuals, SGM
people of color, SGM older adults).

A number of studies showed positive results for reducing alcohol,
tobacco, and methamphetamine use among SGM individuals. In most
cases, these were individual psychotherapies—CBT and CM were the
most common efficacious modalities. Interventions that used MI (e.g.,
motivational interviewing, motivational enhancement therapy [MET])
were the next most common. This is consistent with research supporting
CBT, CM, and MI/MET as evidence-based treatments for a variety of
SUDs (Carroll & Onken, 2005; Miller et al., 2003; Prendergast et al.,
2006). For alcohol, personalized normative feedback also demonstrated
efficacy. Each of the efficacious alcohol interventions utilized the
evidence-based platforms of standard CBT, CM, or MI/MET in combi
nation with adaptations for specific groups of SM individuals.
Most of the studies reviewed focused exclusively on individual-level
interventions. Venue-based and macro-level interventions were under
represented but showed promise in improving substance use outcomes.
These included bar-level interventions to promote lower alcohol con
sumption among patrons at SGM-oriented bars, and local smoke-free
ordinances targeting the population at large. Although conducting an
RCT with individuals is arguably easier than conducting it with multiple
people, a need exists for RCTs with couples and groups. Given a robust
body of literature documenting the importance of using an ecological
framework in addressing individual, interpersonal, and environmental
factors impacting substance use (DeJong & Langford, 2002; Jalali et al.,
2020), a need also exists for additional research that examines inter
personal and environmental strategies for prevention and early inter
vention to reduce substance-related problems among SGM individuals.
A gap in the literature exists regarding the benefits of culturally
adapted substance-use interventions for SGM populations. While many
of the studies included in this review focused on interventions that
incorporated elements intended to be responsive to the needs and per
spectives of SGM individuals, only nine studies directly compared
tailored and nontailored versions of an intervention (Carrico et al.,
2018; Carrico, Gómez, et al., 2015; Morgenstern et al., 2007; Reback
et al., 2018; Reback et al., 2019; Reback & Shoptaw, 2014; Shoptaw
et al., 2005; Shoptaw et al., 2008; Starks et al., 2019); all but two
(Morgenstern et al., 2007; Starks et al., 2019) focused on metham
phetamine use. This limits our ability to draw conclusions about the
relative effectiveness of cultural adaptation for SGM populations. The
adaptations that showed promise focused on unique aspects of substance
use among SGM individuals (e.g., the connection between metham
phetamine use and unprotected sex) and/or unique substance use–re
lated risk factors among SGM, including minority stress. Minority stress
is an additive stress experienced by marginalized populations as a result
of discrimination, internalized stigma, and societal prejudice (Hendricks
& Testa, 2012; Meyer, 2003). Minority stress is associated with elevated
rates of substance use among SGM individuals (Gilbert et al., 2018;
Hughes et al., 2020; Kidd, Jackman, et al., 2018), who often cite coping
with minority stress as a motivation for substance use (Staples et al.,
2018). Research is needed to develop and evaluate the relative effec
tiveness of interventions that integrate minority stress or other relevant
adaptations for SGM populations.
Even though FDA-approved medications are available to treat

5. Conclusion
Overall, substance use prevention and treatment are understudied
areas of SGM health research. This scoping review highlights several
areas for future study. First, a need exists for greater focus on in
terventions for SMW, GM individuals, SGM people of color, and SGM
populations outside of the United States. Next, research needs to expand
beyond interventions targeting alcohol, tobacco, and methamphetamine
use, particularly given emerging evidence of elevated rates of opioid use
among SM populations. Third, a need exists for studies of dyadic,
structural, and medication interventions for SGM substance use as well
as research that compares SGM-specific treatments to standard in
terventions. Finally, in addition to SGM-specific studies, all substance
use clinical trials should include sexual orientation and gender identity
measures (Sexual Minority Assessment Research Team, 2009; The
GenIUSS Group, 2014) to understand how candidate interventions
impact substance use among SGM individuals.
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